loading
전일 마감가:
$5.28
열려 있는:
$5.3
하루 거래량:
231.81K
Relative Volume:
0.80
시가총액:
$144.36M
수익:
$832.00K
순이익/손실:
$-135.12M
주가수익비율:
-8.3846
EPS:
-0.65
순현금흐름:
$-124.69M
1주 성능:
-2.68%
1개월 성능:
-3.02%
6개월 성능:
-52.98%
1년 성능:
+21.34%
1일 변동 폭
Value
$5.30
$5.5599
1주일 범위
Value
$5.25
$5.80
52주 변동 폭
Value
$3.888
$14.75

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name
명칭
Inovio Pharmaceuticals Inc
Name
전화
(858) 410-3134
Name
주소
6769 MESA RIDGE RD., SAN DIEGO, PA
Name
직원
122
Name
트위터
@inoviopharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
INO's Discussions on Twitter

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-09 다운그레이드 Maxim Group Buy → Hold
2022-11-01 다운그레이드 BofA Securities Neutral → Underperform
2022-07-19 재개 RBC Capital Mkts Sector Perform
2022-05-11 다운그레이드 Oppenheimer Outperform → Perform
2022-01-21 업그레이드 BofA Securities Underperform → Neutral
2021-12-29 재개 Jefferies Hold
2021-09-10 다운그레이드 BofA Securities Neutral → Underperform
2021-06-24 개시 Jefferies Hold
2021-03-23 개시 BofA Securities Neutral
2021-02-12 개시 Oppenheimer Outperform
2020-11-17 다운그레이드 ROTH Capital Neutral → Sell
2020-11-10 업그레이드 ROTH Capital Sell → Neutral
2020-09-28 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2020-09-28 업그레이드 Maxim Group Hold → Buy
2020-07-01 다운그레이드 Maxim Group Buy → Hold
2020-07-01 다운그레이드 ROTH Capital Neutral → Sell
2020-06-29 다운그레이드 H.C. Wainwright Buy → Neutral
2020-06-26 다운그레이드 Stifel Buy → Hold
2020-05-21 개시 The Benchmark Company Buy
2020-04-30 다운그레이드 ROTH Capital Buy → Neutral
2020-03-13 다운그레이드 Piper Sandler Overweight → Neutral
2020-03-13 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2019-12-19 개시 ROTH Capital Buy
2018-02-15 재확인 Maxim Group Buy
2017-10-18 개시 RBC Capital Mkts Outperform
2017-09-06 개시 Citigroup Buy
2017-06-08 업그레이드 Piper Jaffray Neutral → Overweight
2017-05-24 재확인 Maxim Group Buy
2017-03-16 업그레이드 Maxim Group Hold → Buy
2017-03-16 다운그레이드 Piper Jaffray Overweight → Neutral
모두보기

Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스

pulisher
Nov 01, 2024

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 01, 2024
pulisher
Oct 31, 2024

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024
pulisher
Oct 30, 2024

Inovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms market - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Inovio Pharmaceuticals (LTS:0A43) Probability of Financial Distress (%) : 0.27% (As of Oct. 30, 2024) - GuruFocus.com

Oct 30, 2024
pulisher
Oct 29, 2024

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 29, 2024
pulisher
Oct 25, 2024

Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 25, 2024
pulisher
Oct 23, 2024

Brokerages Set Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Target Price at $43.80 - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP - StockTitan

Oct 21, 2024
pulisher
Oct 20, 2024

Indo-Asian News Service - IANS India Pvt Ltd

Oct 20, 2024
pulisher
Oct 18, 2024

Global DNA Nanotechnology Market Future Market Projections: - openPR

Oct 18, 2024
pulisher
Oct 16, 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Inovio Pharmaceuticals (LTS:0A43) Change In Prepaid Assets : $-2.12 Mil (TTM As of Jun. 2024) - GuruFocus.com

Oct 15, 2024
pulisher
Oct 14, 2024

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch

Oct 14, 2024
pulisher
Oct 09, 2024

Inovio Pharmaceuticals, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2011; Promotes Niranjan Y. Sardesai as Chief Operating Officer from Senior Vice President Research and Development - Marketscreener.com

Oct 09, 2024
pulisher
Oct 09, 2024

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 09, 2024
pulisher
Oct 09, 2024

Covid-19 Vaccine Market Industry Survey Research Report 2032 – Top Player as Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, Codagenix – Cauverynews - Cauverynews

Oct 09, 2024
pulisher
Oct 09, 2024

Inovio (INO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Inovio Pharmaceuticals, Inc. Announces Leadership Appointments - Marketscreener.com

Oct 08, 2024
pulisher
Oct 08, 2024

INOVIO Announces Equity Grants for New Employees Under 2022 Inducement Plan - MSN

Oct 08, 2024
pulisher
Oct 04, 2024

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Oct 04, 2024
pulisher
Oct 04, 2024

The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts - Benzinga

Oct 04, 2024
pulisher
Oct 04, 2024

Inovio Pharmaceuticals (NASDAQ:INO) Price Target Lowered to $7.00 at Royal Bank of Canada - MarketBeat

Oct 04, 2024
pulisher
Oct 02, 2024

INOVIO Reports Inducement Grants Under Inducement Plan - Marketscreener.com

Oct 02, 2024
pulisher
Oct 01, 2024

INOVIO to Present at Upcoming Scientific Conferences - Marketscreener.com

Oct 01, 2024
pulisher
Sep 30, 2024

Inovio Pharmaceuticals: Takes Another Torpedo But Keeps On Sailing - Seeking Alpha

Sep 30, 2024
pulisher
Sep 30, 2024

Inovio Pharmaceuticals' SWOT analysis: stock faces challenges amid pipeline potential - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives $44.00 Average PT from Analysts - MarketBeat

Sep 28, 2024
pulisher
Sep 18, 2024

Inari medical director Hoffman sells over $1.8m in company stock - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

INVO Bioscience (NASDAQ:INVO) Stock Price Down 1.7% - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

INOVIO to Present at Upcoming Scientific Conference - Lelezard

Sep 17, 2024
pulisher
Sep 16, 2024

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Sep 16, 2024
pulisher
Sep 13, 2024

Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 - sharewise

Sep 13, 2024
pulisher
Sep 12, 2024

Page 2 | INOVIO PHARMACEUTICALS INC Trade Ideas — GETTEX:GBMB - TradingView

Sep 12, 2024
pulisher
Sep 11, 2024

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Sep 11, 2024
pulisher
Sep 10, 2024

Inovio Pharmaceuticals Inc. stock rises Tuesday, still underperforms market - MarketWatch

Sep 10, 2024

Inovio Pharmaceuticals Inc (INO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.56
price up icon 1.08%
$76.13
price up icon 2.71%
$374.02
price up icon 0.01%
$54.63
price up icon 0.50%
$204.21
price up icon 0.77%
$111.48
price down icon 1.43%
자본화:     |  볼륨(24시간):